PlainRecalls
FDA Drug Moderate Class II Terminated

Amoxicillin for Oral Suspension USP, 125 mg per 5 mL, packaged in a 100 mL bottle, Rx only, Manufactured for: TEVA PHARMACEUTICALS USA, Sellersville, PA 18960, NDC 0093-4150-73

Reported: February 1, 2017 Initiated: December 21, 2016 #D-0440-2017

Product Description

Amoxicillin for Oral Suspension USP, 125 mg per 5 mL, packaged in a 100 mL bottle, Rx only, Manufactured for: TEVA PHARMACEUTICALS USA, Sellersville, PA 18960, NDC 0093-4150-73

Reason for Recall

Subpotency: due to a low, out of specification test result for assay during stability testing.

Details

Recalling Firm
Teva Pharmaceuticals USA
Units Affected
133,601 bottles
Distribution
United States and Puerto Rico
Location
North Wales, PA

Frequently Asked Questions

What product was recalled?
Amoxicillin for Oral Suspension USP, 125 mg per 5 mL, packaged in a 100 mL bottle, Rx only, Manufactured for: TEVA PHARMACEUTICALS USA, Sellersville, PA 18960, NDC 0093-4150-73. Recalled by Teva Pharmaceuticals USA. Units affected: 133,601 bottles.
Why was this product recalled?
Subpotency: due to a low, out of specification test result for assay during stability testing.
Which agency issued this recall?
This recall was issued by the FDA Drug on February 1, 2017. Severity: Moderate. Recall number: D-0440-2017.